VICL: Analysis & Opinions

  1. Vical's Loss Narrower than Expected - Analyst Blog

    February 08, 2013
    Vical Inc. (VICL) suffered a net loss per share of 9 cents in the fourth quarter of 2012, narrower than the Zacks ...
  2. Vical and Bristol-Myers Ink Deal - Analyst Blog

    September 17, 2012
    Vical Incorporated (VICL) recently signed an agreement with Bristol-Myers Squibb Company (BMY) providing the latter ...
  3. Abbott-Astellas Collaborate - Analyst Blog

    September 13, 2012
    Abbott Laboratories (ABT) recently announced that it is collaborating with Astellas Pharma Global Development for a ...
  4. XOMA Rearranges The Deck Chairs One More Time

    September 02, 2011
    XOMA changes management again, but should anybody care?
  5. Vical Gets Some Validation

    July 19, 2011
    Vical gets a small victory with a partnership for its CMV drug.
  6. SciClone Pharmaceuticals' Chinese Adventure

    February 10, 2011
    The micro-cap drug development company looks to expand its presence in China, which means good things for its future.
  7. Cancer Vaccines Continue To Show Promise

    July 07, 2010
    Dendreon has put cancer vaccines back in the spotlight, but can they live up to their hype?
Marketplace
Trading Center